![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 35359 |
FusionGeneSummary for SOD1_CXCL9 |
![]() |
Fusion gene information | Fusion gene name: SOD1_CXCL9 | Fusion gene ID: 35359 | Hgene | Tgene | Gene symbol | SOD1 | CXCL9 | Gene ID | 6647 | 4283 |
Gene name | superoxide dismutase 1 | C-X-C motif chemokine ligand 9 | |
Synonyms | ALS|ALS1|HEL-S-44|IPOA|SOD|hSod1|homodimer | CMK|Humig|MIG|SCYB9|crg-10 | |
Cytomap | 21q22.11 | 4q21.1 | |
Type of gene | protein-coding | protein-coding | |
Description | superoxide dismutase [Cu-Zn]Cu/Zn superoxide dismutaseSOD, solubleepididymis secretory protein Li 44indophenoloxidase Asuperoxide dismutase 1, solublesuperoxide dismutase, cystolic | C-X-C motif chemokine 9chemokine (C-X-C motif) ligand 9gamma-interferon-induced monokinemonokine induced by gamma interferonmonokine induced by interferon-gammasmall-inducible cytokine B9 | |
Modification date | 20180527 | 20180523 | |
UniProtAcc | P00441 | Q07325 | |
Ensembl transtripts involved in fusion gene | ENST00000270142, ENST00000389995, ENST00000470944, | ENST00000264888, | |
Fusion gene scores | * DoF score | 3 X 3 X 1=9 | 3 X 2 X 3=18 |
# samples | 3 | 3 | |
** MAII score | log2(3/9*10)=1.73696559416621 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: SOD1 [Title/Abstract] AND CXCL9 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | SOD1 | GO:0000303 | response to superoxide | 16790527 |
Hgene | SOD1 | GO:0001819 | positive regulation of cytokine production | 15544046 |
Hgene | SOD1 | GO:0006801 | superoxide metabolic process | 12551919 |
Hgene | SOD1 | GO:0010033 | response to organic substance | 12921788 |
Hgene | SOD1 | GO:0032930 | positive regulation of superoxide anion generation | 18219391 |
Hgene | SOD1 | GO:0043085 | positive regulation of catalytic activity | 17324120 |
Hgene | SOD1 | GO:0043087 | regulation of GTPase activity | 18219391 |
Hgene | SOD1 | GO:0045541 | negative regulation of cholesterol biosynthetic process | 15473258 |
Hgene | SOD1 | GO:0045859 | regulation of protein kinase activity | 16254550 |
Hgene | SOD1 | GO:0050665 | hydrogen peroxide biosynthetic process | 15544046 |
Hgene | SOD1 | GO:0060047 | heart contraction | 9539776 |
Hgene | SOD1 | GO:0072593 | reactive oxygen species metabolic process | 24140062 |
Tgene | CXCL9 | GO:0006935 | chemotaxis | 12782716 |
Tgene | CXCL9 | GO:0030816 | positive regulation of cAMP metabolic process | 12782716 |
Tgene | CXCL9 | GO:0042127 | regulation of cell proliferation | 12782716 |
Tgene | CXCL9 | GO:0043950 | positive regulation of cAMP-mediated signaling | 12782716 |
Tgene | CXCL9 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol | 12782716 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | AW389351 | SOD1 | chr21 | 33040852 | + | CXCL9 | chr4 | 76924037 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-3UTR | ENST00000270142 | ENST00000264888 | SOD1 | chr21 | 33040852 | + | CXCL9 | chr4 | 76924037 | + |
5CDS-3UTR | ENST00000389995 | ENST00000264888 | SOD1 | chr21 | 33040852 | + | CXCL9 | chr4 | 76924037 | + |
3UTR-3UTR | ENST00000470944 | ENST00000264888 | SOD1 | chr21 | 33040852 | + | CXCL9 | chr4 | 76924037 | + |
Top |
FusionProtFeatures for SOD1_CXCL9 |
![]() |
Hgene | Tgene |
SOD1 | CXCL9 |
Cytokine that affects the growth, movement, oractivation state of cells that participate in immune andinflammatory response. Chemotactic for activated T-cells. Binds toCXCR3. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for SOD1_CXCL9 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for SOD1_CXCL9 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for SOD1_CXCL9 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | SOD1 | P00441 | DB00988 | Dopamine | Superoxide dismutase [Cu-Zn] | small molecule | approved |
Hgene | SOD1 | P00441 | DB01064 | Isoprenaline | Superoxide dismutase [Cu-Zn] | small molecule | approved|investigational |
Hgene | SOD1 | P00441 | DB01593 | Zinc | Superoxide dismutase [Cu-Zn] | small molecule | approved|investigational |
Hgene | SOD1 | P00441 | DB00668 | Epinephrine | Superoxide dismutase [Cu-Zn] | small molecule | approved|vet_approved |
Top |
RelatedDiseases for SOD1_CXCL9 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | SOD1 | C1862939 | AMYOTROPHIC LATERAL SCLEROSIS 1 | 51 | CTD_human;UNIPROT |
Hgene | SOD1 | C0002736 | Amyotrophic Lateral Sclerosis | 24 | CTD_human;HPO;ORPHANET |
Hgene | SOD1 | C0007787 | Transient Ischemic Attack | 4 | CTD_human |
Hgene | SOD1 | C0035126 | Reperfusion Injury | 4 | CTD_human |
Hgene | SOD1 | C0011581 | Depressive disorder | 3 | CTD_human;HPO;PSYGENET |
Hgene | SOD1 | C0027746 | Nerve Degeneration | 3 | CTD_human;HPO |
Hgene | SOD1 | C0030567 | Parkinson Disease | 3 | CTD_human |
Hgene | SOD1 | C0007621 | Neoplastic Cell Transformation | 2 | CTD_human |
Hgene | SOD1 | C0011570 | Mental Depression | 2 | PSYGENET |
Hgene | SOD1 | C0020538 | Hypertensive disease | 2 | CTD_human |
Hgene | SOD1 | C0035304 | Retinal Degeneration | 2 | CTD_human |
Hgene | SOD1 | C0003493 | Aortic Diseases | 1 | CTD_human |
Hgene | SOD1 | C0004045 | Asphyxia Neonatorum | 1 | CTD_human |
Hgene | SOD1 | C0004096 | Asthma | 1 | CTD_human |
Hgene | SOD1 | C0004153 | Atherosclerosis | 1 | CTD_human |
Hgene | SOD1 | C0005586 | Bipolar Disorder | 1 | PSYGENET |
Hgene | SOD1 | C0007786 | Brain Ischemia | 1 | CTD_human |
Hgene | SOD1 | C0011616 | Contact Dermatitis | 1 | CTD_human |
Hgene | SOD1 | C0011849 | Diabetes Mellitus | 1 | CTD_human |
Hgene | SOD1 | C0011853 | Diabetes Mellitus, Experimental | 1 | CTD_human |
Hgene | SOD1 | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | CTD_human |
Hgene | SOD1 | C0011884 | Diabetic Retinopathy | 1 | CTD_human |
Hgene | SOD1 | C0013080 | Down Syndrome | 1 | CTD_human |
Hgene | SOD1 | C0015696 | Fatty Liver, Alcoholic | 1 | CTD_human |
Hgene | SOD1 | C0015934 | Fetal Growth Retardation | 1 | CTD_human |
Hgene | SOD1 | C0017638 | Glioma | 1 | CTD_human |
Hgene | SOD1 | C0018801 | Heart failure | 1 | CTD_human |
Hgene | SOD1 | C0019054 | Hemolysis (disorder) | 1 | CTD_human |
Hgene | SOD1 | C0019189 | Hepatitis, Chronic | 1 | CTD_human |
Hgene | SOD1 | C0020550 | Hyperthyroidism | 1 | CTD_human |
Hgene | SOD1 | C0020649 | Hypotension | 1 | CTD_human |
Hgene | SOD1 | C0020672 | Hypothermia, natural | 1 | CTD_human |
Hgene | SOD1 | C0021368 | Inflammation | 1 | CTD_human |
Hgene | SOD1 | C0022116 | Ischemia | 1 | CTD_human |
Hgene | SOD1 | C0022650 | Kidney Calculi | 1 | CTD_human |
Hgene | SOD1 | C0023895 | Liver diseases | 1 | CTD_human |
Hgene | SOD1 | C0024796 | Marfan Syndrome | 1 | CTD_human |
Hgene | SOD1 | C0025312 | Meningomyelocele | 1 | CTD_human |
Hgene | SOD1 | C0026846 | Muscular Atrophy | 1 | CTD_human |
Hgene | SOD1 | C0027051 | Myocardial Infarction | 1 | CTD_human |
Hgene | SOD1 | C0027540 | Necrosis | 1 | CTD_human |
Hgene | SOD1 | C0027720 | Nephrosis | 1 | CTD_human |
Hgene | SOD1 | C0027765 | nervous system disorder | 1 | CTD_human |
Hgene | SOD1 | C0028754 | Obesity | 1 | CTD_human |
Hgene | SOD1 | C0033626 | Protein Deficiency | 1 | CTD_human |
Hgene | SOD1 | C0033687 | Proteinuria | 1 | CTD_human |
Hgene | SOD1 | C0036330 | Schistosomiasis mansoni | 1 | CTD_human |
Hgene | SOD1 | C0036341 | Schizophrenia | 1 | PSYGENET |
Hgene | SOD1 | C0036457 | Scrapie | 1 | CTD_human |
Hgene | SOD1 | C0038454 | Cerebrovascular accident | 1 | CTD_human |
Hgene | SOD1 | C0041408 | Turner Syndrome | 1 | CTD_human |
Hgene | SOD1 | C0085084 | Motor Neuron Disease | 1 | CTD_human |
Hgene | SOD1 | C0162316 | Iron deficiency anemia | 1 | CTD_human |
Hgene | SOD1 | C0162671 | MELAS Syndrome | 1 | CTD_human |
Hgene | SOD1 | C0162674 | Chronic progressive external ophthalmoplegia | 1 | CTD_human |
Hgene | SOD1 | C0751830 | Gait Disorders, Neurologic | 1 | CTD_human |
Hgene | SOD1 | C0919267 | ovarian neoplasm | 1 | CTD_human |
Hgene | SOD1 | C1262477 | Weight decreased | 1 | CTD_human |
Hgene | SOD1 | C1384666 | hearing impairment | 1 | CTD_human |
Hgene | SOD1 | C1456865 | Ureteral Calculi | 1 | CTD_human |
Hgene | SOD1 | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
Tgene | CXCL9 | C0002171 | Alopecia Areata | 1 | CTD_human |
Tgene | CXCL9 | C0020517 | Hypersensitivity | 1 | CTD_human |
Tgene | CXCL9 | C0023892 | Biliary cirrhosis | 1 | CTD_human |
Tgene | CXCL9 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Tgene | CXCL9 | C0023904 | Liver Neoplasms, Experimental | 1 | CTD_human |
Tgene | CXCL9 | C0027643 | Neoplasm Recurrence, Local | 1 | CTD_human |
Tgene | CXCL9 | C0032285 | Pneumonia | 1 | CTD_human |
Tgene | CXCL9 | C0282488 | Interstitial Cystitis | 1 | CTD_human |
Tgene | CXCL9 | C0345967 | Malignant mesothelioma | 1 | CTD_human |
Tgene | CXCL9 | C1458155 | Mammary Neoplasms | 1 | CTD_human |